NePtune: A Phase 2 Study of Neoadjuvant PARP Inhibition followed by Radical Prostatectomy in Patients with Unfavorable Intermediate-Risk or High-Risk Prostate Cancer with BRCA1/2 Gene Alterations
RR McKay, L Liu, M Pu, A Araneta, L Wang, N Castano, J Gomez, A Ajmera, H Ye, R Pili, K Runcie, D Joseph McHugh, K Offit, C Judith Paller, NB Haas, J Javier-Desloges, CJ Kane, TM Seibert, A Bagrodia
Trial Locations
All sites in which the trial HCRN-GU20-436 being conducted in.
